wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38266308-18A63F7F-BA34-4C6F-810C-747A8377B572
Q38266308-18A63F7F-BA34-4C6F-810C-747A8377B572
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38266308-18A63F7F-BA34-4C6F-810C-747A8377B572
Personalized treatment of EGFR mutant and ALK-positive patients in NSCLC.
P2860
Q38266308-18A63F7F-BA34-4C6F-810C-747A8377B572
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38266308-18A63F7F-BA34-4C6F-810C-747A8377B572
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
03bd24e392e76220be3347aaecddb3d38297b33b
P2860
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial.